Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
YES Partners with Singapore's Gaia Science 2020-12-07 09:00
Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study 2020-12-07 08:00
CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition 2020-12-06 19:00
Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BCMA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Multiple Myeloma at 2020 ASH Annual Meeting 2020-12-06 04:30
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch 2020-12-04 20:00
Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study 2020-12-04 08:00
VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors 2020-12-03 21:30
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A. 2020-12-03 21:00
Antengene Submits NDAs for XPOVIO® (Selinexor) in Multiple APAC Markets for rrMM and rrDLBCL 2020-12-03 20:00
WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award 2020-12-03 08:00
WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research 2020-12-02 22:00
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years 2020-12-02 20:00
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation 2020-12-02 19:00
Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia 2020-12-02 08:09
Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S. 2020-12-01 21:45
ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy 2020-12-01 21:00
Kaltech's Disinfectant Deodorizer Proved to Have Infectivity Suppression Effect against Novel Coronavirus (COVID-19) Floating in Fixed Space 2020-12-01 14:05
Taiwan-based Enterprises AP Biosciences and LuminX Novel Cancer Treatments 2020-12-01 00:00
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19 2020-11-30 10:45
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology 2020-11-30 08:09